With an increasingly promising roster of approved cell therapies still burdened by complex manufacturing, multiple companies ...

FREMONT, Calif.--(BUSINESS WIRE)--Celltrio®, a pioneering life sciences company delivering advanced automation solutions for cell culturing and cell & gene therapy, today announced the closing of a ...

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...

Automation will help the cell therapy sector reduce the number of expert staff needed to manufacture these lifesaving therapies, thereby making them more affordable. A team, led by researchers at the ...